SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aphton (apht)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mason630 who wrote (83)11/22/1998 10:42:00 AM
From: rocket  Read Replies (1) of 95
 
I saw the news release and was pleased. It appears Pasteu merieux Connaught is happy with their affiliation with Aphton. Although this may not be too intelligent, I'm going to infer the phase 3 trial that APHT and PMC have going in England for stomach cancer must be going well---otherwise, why start a new trial for a new indication if the medication isn't working? I hope to keep buying when dips occur. Hang in there. Karl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News